Search

Your search keyword '"Raikhelkar J"' showing total 577 results

Search Constraints

Start Over You searched for: Author "Raikhelkar J" Remove constraint Author: "Raikhelkar J"
577 results on '"Raikhelkar J"'

Search Results

1. Correlation Between the Subtype of Anti-HLA Donor Specific Antibodies and Rejection Assessed by Molecular Microscope

2. History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx)

3. Heart Transplantation in a Patient with Active Thyroid Cancer

4. Sublingual Microcirculation in Acute Mechanical Circulatory Support in Cardiogenic Shock

7. Implications of ABO Unmatched Donors on Cardiac Allograft Rejection Assessed by the Molecular Microscope (MMDx)

8. Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed

9. Sex Differences in Allograft Rejection After Heart Transplantation (HT). Molecular Microscope (MMDx) Results

10. Microcirculatory Dysfunction in Cardiogenic Shock

11. Molecular Microscope (MMDx) Results in the Sensitized Heart Transplant Recipient

13. Association of Sex Mismatch with Allograft Rejection After Heart Transplantation (HT) - Molecular Microscope (MMDx) Results

14. Clinical Utility of Molecular Microscope Diagnostic System (MMDx) in Heart Transplant Recipients: Moving Towards a New Paradigm

15. Inflammatory Cardiomyopathies are Associated with Higher Rates of T-Cell Mediated Rejection. Molecular Microscope Results

16. Impact of MTOR Inhibitors on Heart Allograft Rejection Using Tissue-Based Gene-Expression Profiling. Molecular Microscope (MMDx) Results

17. Does Multiorgan Transplantation Correlate with Reduced Rates of Rejection as Evaluated by the Molecular Microscope (MMDx)?

18. Impact and Outcomes of Induction Therapy on Donor-Derived Cell-Free DNA Levels and Peripheral Gene-Expression Profiling in Heart Transplant Recipients

19. LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope

20. Impact of Epstein-Barr Virus (EBV) Mismatch on Gene-Expression Profiling (MMDx) and Rejection

21. Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus

23. Molecular Microscope (MMDx) After COVID-19 Vaccination in Heart Transplant Recipients

24. Correlation Between High-Sensitivity Troponin-T and Molecular Microscope Results (MMDx)

25. Effects of Belatacept Therapy on Gene Expression Profiling and Rejection in Heart Transplant Recipients: A Molecular Microscope (MMDx) Evaluation

26. CAV Grading by PET Provides Improved Risk Stratification Compared to CA

27. Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients

28. Myocardial Blood Flow Assessment with PET Improves Risk Stratification Among HT Recipients with CAV1

29. Is There A Correlation Between a High Immuknow Level and Increased Rates of Rejection? Insights from Molecular Microscope (MMDx)

30. What is Behind the Quilty Effect? Molecular Microscope Insights

31. Clinical Implications of Borderline Rejection Assessed by Molecular Microscope

32. Comparison of Microcirculatory Function in Patients with HeartMate 3 LVAD and Healthy Controls

33. Impact of MIC-A Antibodies on Antibody Mediated Rejection (ABMR). Molecular Microscope Results (MMDx)

34. Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients

35. Impact of Cytomegalovirus (CMV) Mismatch on Rejection Assessed by Molecular Microscope (MMDx)

36. Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients

37. Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls

38. Microcirculatory Dysfunction Across SCAI Stages of Cardiogenic Shock

39. (280) Comparison of Two Commercially Available Donor-Derived Cell-Free DNA Assays for Surveillance of Rejection in Heart Transplant Recipients

40. (230) The Effect of Preservation Modality on Myocardial Injury - A Single Blinded Study

41. (793) Validation of the Heartmate 3 Survival Risk Score in a Large Left Ventricular Assist Device Center

42. (1029) Donor-Derived Cell-Free DNA in Heart Transplant Recipients with a History of Congenital Heart Disease

43. (272) Isolated Microvascular Cardiac Allograft Vasculopathy is Associated with an Increased Risk of Death or Retransplantation

44. Visually Estimated Coronary Artery Calcium is an Independent Prognostic Marker Following Heart Transplantation

45. (175) Characteristics and Outcomes of Multiple Cardiac Re-Transplant Recipients

47. Long-Term Outcomes for Pediatric HT Patients Transitioning to Adult Care

48. New-Onset Diabetes in Patients Post-Heart Transplantation; the Role of Hypertension and Novel Diabetic Medications

50. Combined Heart Kidney Transplantation in a Previous Heart Transplant Recipient with Pheochromocytoma and Monoclonal Gammopathy of Uncertain Significance

Catalog

Books, media, physical & digital resources